Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 3 out of 28 pages
Exam (elaborations)

PMHNP Certification Advanced Prep: Master Psychopharmacology & Clinical Management Practice Questions & Detailed Explanations

Document preview thumbnail
Preview 3 out of 28 pages

PMHNP Certification Advanced Prep: Master Psychopharmacology & Clinical Management Practice Questions & Detailed Explanations

Content preview

,PMHNP Certification Advanced Prep: Master
Psychopharmacology & Clinical Management
Practice Questions & Detailed Explanations
Subject: Psychiatric-Mental Health Nurse Practitioner (PMHNP) –
Psychopharmacology and Advanced Clinical Management
Question 1: A 42-year-old patient with Treatment-Resistant Depression (TRD) is currently stabilized
on an antidepressant. The clinician considers adding a second-generation antipsychotic (SGA) as
an augmentation strategy. Which of the following mechanisms best explains the synergistic
antidepressant effect observed with low-dose aripiprazole augmentation?

A) Potent blockade of the $H_1$ histamine receptors leading to improved sleep architecture.

B) Partial agonism at the $D_2$ and $5-HT_{1A}$ receptors, modulating dopaminergic and
serotonergic tone in the prefrontal cortex.

C) Strong antagonism at the $5-HT_{2C}$ receptors, rapidly increasing downstream
norepinephrine release.

D) Irreversible inhibition of monoamine oxidase A, significantly increasing synaptic serotonin
concentrations.

Correct Answer: B) Partial agonism at the $D_2$ and $5-HT_{1A}$ receptors, modulating
dopaminergic and serotonergic tone in the prefrontal cortex.

*Explanation: Aripiprazole is a $D_2$ and $5-HT_{1A}$ partial agonist. By acting as a
"stabilizer," it provides partial dopaminergic stimulation in hypodopaminergic states associated
with depression, while simultaneously blocking overactive receptors in other pathways. This
modulation is distinct from simple antagonism. Distractor C describes the mechanism of
mirtazapine, and D is incorrect as aripiprazole is not an MAOI.

Question 2: A patient diagnosed with Bipolar I Disorder is being managed with lithium
carbonate. During a routine follow-up, the patient’s serum creatinine level rises from 0.9 mg/dL
to 1.3 mg/dL. What is the most clinically appropriate next step?

A) Discontinue lithium immediately and initiate carbamazepine.

B) Order a 24-hour urine collection for creatinine clearance and evaluate for potential
nephrogenic diabetes insipidus.

C) Maintain the current lithium dose but add a thiazide diuretic to compensate for the fluid
retention.

, D) Switch to lamotrigine to avoid further renal impact.

Correct Answer: B) Order a 24-hour urine collection for creatinine clearance and evaluate
for potential nephrogenic diabetes insipidus.

*Explanation: Lithium is renally excreted and has a known potential for nephrotoxicity,
including decreased glomerular filtration rate (GFR) and nephrogenic diabetes insipidus. An
increase in creatinine warrants a formal assessment of renal function (clearance) rather than
just serum levels. Thiazide diuretics (Distractor C) are contraindicated as they decrease lithium
clearance, leading to toxicity.

Question 3: Which receptor binding profile is most associated with the side effect of orthostatic
hypotension in patients taking clozapine?

A) $D_2$ receptor antagonism.

B) $\alpha_1$-adrenergic receptor antagonism.

C) $5-HT_2$ receptor antagonism.

D) $M_1$ muscarinic receptor antagonism.

Correct Answer: B) $\alpha_1$-adrenergic receptor antagonism.

*Explanation: Orthostatic hypotension is primarily mediated by the blockade of $\alpha_1$-
adrenergic receptors, which inhibits the compensatory vasoconstriction necessary when
changing positions. While clozapine has high affinity for many receptors, $\alpha_1$ blockade is
the pharmacological driver of this specific cardiovascular side effect.

Question 4: A patient presents with signs of Neuroleptic Malignant Syndrome (NMS). Which
agent is the most appropriate pharmacological intervention to counteract the rigidity and
hyperthermia?

A) Benztropine.

B) Lorazepam.

C) Dantrolene.

D) Diphenhydramine.

Correct Answer: C) Dantrolene.

*Explanation: NMS is a life-threatening reaction to antipsychotic use, characterized by severe
muscle rigidity, hyperthermia, and autonomic instability. Dantrolene acts as a direct skeletal
muscle relaxant by inhibiting the release of calcium from the sarcoplasmic reticulum. While

Document information

Uploaded on
July 10, 2026
Number of pages
28
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$23.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
1
Followers
1
Items
722
Last sold
1 month ago


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions